FDA HAS APPROVED THE FIRST THERAPY FOR NEUROENDOCRINE TUMORS IN CHILDREN

Pediatric pharmacology
Pediatričeskaâ farmakologiâ

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

eng | рус

Pediatric pharmacology

Advanced search

FDA HAS APPROVED THE FIRST THERAPY FOR NEUROENDOCRINE TUMORS IN CHILDREN. Pediatric pharmacology. 2024;21(3):295-296. (In Russ.)

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?